When you need to dive in the deep end-Transplanting SARS-CoV-2 PCR+ recipients.
COVID-19
SARS-CoV-2
organ transplantation
Journal
Transplant infectious disease : an official journal of the Transplantation Society
ISSN: 1399-3062
Titre abrégé: Transpl Infect Dis
Pays: Denmark
ID NLM: 100883688
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
revised:
06
07
2023
received:
28
03
2023
accepted:
17
07
2023
medline:
23
10
2023
pubmed:
1
8
2023
entrez:
1
8
2023
Statut:
ppublish
Résumé
There is an ongoing need to understand whether transplantation during acute Coronavirus disease 2019 (COVID-19) can be performed safely, especially when urgent transplant is required. We collected retrospective data of all consecutive non-lung transplant recipients who had a positive SARS-CoV-2 polymerase chain reaction (PCR) on the day of planned deceased donor organ implantation. Data were collected from two large transplant centers from 01/01/2022 to 02/01/2023. Demographics, details regarding COVID-19 infection, waitlist priority, and details regarding transplantation were obtained. A descriptive analysis was performed. A total of 12 patients were identified: 7 renal, 4 liver, and 1 heart transplant recipient. All 12 patients were vaccinated for COVID-19. Ten were asymptomatic outpatients found positive on admission and transplanted immediately. Two were in-patients with mild COVID-19 symptoms and were reactivated on the waitlist following 3 days of remdesivir when no progression to severe COVID-19 occurred. Most patients (10/12) received remdesivir posttransplant. No complications attributed to COVID-19 were noted nor were any secondary family or healthcare worker infections observed. All recipients were managed with special isolation precautions befitting their potentially infectious state. Standard induction therapy was used in all recipients. After a median follow up period of 143 days (interquartile range: 96-201 days), 3 episodes of rejection were documented, 2/7 renal recipients experienced delayed graft function, and 2/4 liver recipients required renal replacement therapy. Graft and patient survival were 100%. Transplantation can safely proceed in select, minimally symptomatic, non-lung recipients with a positive SARS-CoV-2 PCR at the time of transplant.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14110Informations de copyright
© 2023 Wiley Periodicals LLC.
Références
Mohan S, King KL, Husain SA, Schold JD. COVID-19-associated mortality among kidney transplant recipients and candidates in the United States. Clin J Am Soc Nephrol. 2021;16(11):1695-1703. https://doi.org/10.2215/CJN.02690221
Sadeh B, Ugolini S, Pinzon OW, et al. Medical decisions in organ donors and heart transplant candidates with history of COVID-19 infection: an international practice survey. Clin Transplant. 2022;36(7):e14733. https://doi.org/10.1111/ctr.14733
Axelrod DA, Ince D, Harhay MN, et al. Operational challenges in the COVID-19 era: asymptomatic infections and vaccination timing. Clin Transplant. 2021;35(11):e14437. https://doi.org/10.1111/ctr.14437
Kaul DR, Valesano AL, Petrie JG, et al. Donor to recipient transmission of SARS-CoV-2 by lung transplantation despite negative donor upper respiratory tract testing. Am J Transplant. 2021;21(8):2885-2889. https://doi.org/10.1111/ajt.16532
Cochran W, Shah P, Barker L, et al. COVID-19 clinical outcomes in solid organ transplant recipients during the omicron surge. Transplantation. 2022;106(7):e346-e347. https://doi.org/10.1097/TP.0000000000004162
Collaborative CO, GlobalSurg C. Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study. Anaesthesia. 2021;76(6):748-758. https://doi.org/10.1111/anae.15458
Kim WR, Biggins SW, Kremers WK, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008;359(10):1018-1026. https://doi.org/10.1056/NEJMoa0801209
Gottlieb RL, Vaca CE, Paredes R, et al. Early remdesivir to prevent progression to severe COVID-19 in outpatients. N Engl J Med. 2022;386(4):305-315. https://doi.org/10.1056/NEJMoa2116846
Kulkarni AV, Parthasarathy K, Kumar P, et al. Early liver transplantation after COVID-19 infection: the first report. Am J Transplant. 2021;21(6):2279-2284. https://doi.org/10.1111/ajt.16509
Manzia TM, Gazia C, Lenci I, et al. Liver transplantation performed in a SARS-CoV-2 positive hospitalized recipient using a SARS-CoV-2 infected donor. Am J Transplant. 2021;21(7):2600-2604. https://doi.org/10.1111/ajt.16548